EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 50 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q4 2022. The put-call ratio across all filers is 55.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $399,000 | – | 40,385 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Investment Advisors LP | 1,326,735 | $12,962,000 | 1.74% |
| Arena Capital Advisors, LLC- CA | 1,597,744 | $15,610,000 | 1.23% |
| HGC Investment Management Inc. | 1,715,000 | $16,756,000 | 1.21% |
| MMCAP International Inc. SPC | 1,000,000 | $9,770,000 | 0.68% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,520,565 | $24,626,000 | 0.65% |
| DARK FOREST CAPITAL MANAGEMENT LP | 157,892 | $1,543,000 | 0.55% |
| Castle Creek Arbitrage, LLC | 728,652 | $7,108,000 | 0.40% |
| ARISTEIA CAPITAL, L.L.C. | 2,011,452 | $19,652,000 | 0.36% |
| Saba Capital Management, L.P. | 1,373,238 | $13,417,000 | 0.33% |
| CVI Holdings, LLC | 500,000 | $4,885,000 | 0.30% |